USAIC Panel 2024: BioPharma Industry & Investment Outlook
HTML-код
- Опубликовано: 21 ноя 2024
- BioPharma Industry & Investment Outlook 2024
Panelists:
Christopher Viehbacher, President & CEO, Biogen
Dilip Shanghvi, Founder & Managing Director, Sun Pharmaceutical Industries
Hari Bhartia, Founder and Co-Chairman, Jubilant Bhartia Group
Rajiv Kaul, Sector Portfolio Manager, Fidelity Investments
Dr. Stelios Papadopoulos, Chairman of the Board, Exelixis
Moderator:
Daphne Zohar, Founder & Chief Executive Officer, Seaport Therapeutics